Multiple sclerosis laboratory findings: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(11 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Template:Multiple sclerosis}}
{{Template:Multiple sclerosis}}
{{CMG}}
{{CMG}}; {{AE}} {{Fs}}
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.


==Overview==
==Overview==
An elevated concentration of [[CSF]] [[oligoclonal bands]] is [[diagnostic]] of multiple sclerosis.


==Laboratory Findings==
==Laboratory Findings==


==== CSF analysis: ====
==== CSF analysis: ====
[[CSF]] analysis mostly used to rule out other [[differential diagnosis]] of [[MS]] since it’s not needed in [[MS]] patients who have typical clinical presentation and [[MRI]] findings. The first thing we see in [[CSF analysis]] is the appearance and [[pressure]] of [[CSF]] which is usually normal in [[MS]] patients. One of the most important findings in [[CSF]] analysis of [[MS]] patients is the presence of [[Oligoclonal bands|oligoclonal IgG bands]] and can be seen in more than 95% of these patients. [[Oligoclonal bands]] are an indicator of disease progression.
* An elevated concentration of [[CSF]] [[oligoclonal bands]] is [[diagnostic]] of multiple sclerosis and can be seen in more than 95% of these patients.<ref name="pmid11456302">{{cite journal |vauthors=McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS |title=Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis |journal=Ann. Neurol. |volume=50 |issue=1 |pages=121–7 |date=July 2001 |pmid=11456302 |doi= |url=}}</ref><ref name="pmid23431079">{{cite journal |vauthors=Dobson R, Ramagopalan S, Davis A, Giovannoni G |title=Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude |journal=J. Neurol. Neurosurg. Psychiatry |volume=84 |issue=8 |pages=909–14 |date=August 2013 |pmid=23431079 |doi=10.1136/jnnp-2012-304695 |url=}}</ref><ref name="pmid2245296">{{cite journal |vauthors=McLean BN, Luxton RW, Thompson EJ |title=A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications |journal=Brain |volume=113 ( Pt 5) |issue= |pages=1269–89 |date=October 1990 |pmid=2245296 |doi= |url=}}</ref>
* [[Oligoclonal bands]] are an indicator of disease progression.
* [[CSF analysis]] is mostly used to rule out other [[differential diagnosis]] of [[MS]] since it’s not needed in [[MS]] patients who have typical [[History and Physical examination|clinical presentation]] and [[MRI]] findings.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Primary care]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Orthopedics]]
[[Category:Orthopedics]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
{{WH}}
{{WS}}

Latest revision as of 22:47, 29 July 2020

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis laboratory findings

CDC on Multiple sclerosis laboratory findings

Multiple sclerosis laboratory findings in the news

Blogs on Multiple sclerosis laboratory findings

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

An elevated concentration of CSF oligoclonal bands is diagnostic of multiple sclerosis.

Laboratory Findings

CSF analysis:

References

  1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121–7. PMID 11456302.
  2. Dobson R, Ramagopalan S, Davis A, Giovannoni G (August 2013). "Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude". J. Neurol. Neurosurg. Psychiatry. 84 (8): 909–14. doi:10.1136/jnnp-2012-304695. PMID 23431079.
  3. McLean BN, Luxton RW, Thompson EJ (October 1990). "A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications". Brain. 113 ( Pt 5): 1269–89. PMID 2245296.

Template:WH Template:WS